Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-03-21
1996-12-10
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3120
Patent
active
055831591
ABSTRACT:
Damage to internal tissues, and particularly to the central nervous system as a consequence of exposure to ionizing radiation is prevented or treated by administration of GLA and/or DGLA. Medicaments containing GLA and/or DGLA for such treatment or prevention may also further comprise EPA and/or DHA.
REFERENCES:
patent: 4996233 (1991-02-01), Horrobin
patent: 4997649 (1991-03-01), Papaconstantin et al.
patent: 5059622 (1991-10-01), Sears
patent: 5271925 (1993-12-01), Sredni et al.
Database WPI Week 9111, Derwent AN 91-075338 Mar. 1991.
Database WPI Week 8951 Derwent AN 89-372299 Dec. 1989.
British Journal of Cancer vol. 68, No. 1, Jul. 1993 pp. 1-7 Hopewell et al "The Modulation of Radiation-induced Damage to Pig Skin by Essential Fatty Acids".
Nutrition Research vol. 5, 1985 pp. 101-105 Das et al "Benzo(a)pyrene and Gamma-Radiation-Induced . . . ".
Prostaglandins, vol. 29, No. 6, Jun. 1985 pp. 911-920 "Prostaglandins and their Precursors Can Modify Genetic Damage Induced by Gamma-Radiation and Benzo(a)pyrene".
European Patent Application 0416855 Mar. 1991, pp. 1, 3 and 5.
Horrobin David F.
Scott Catherine A.
Henley III Raymond
Scotia Holdings PLC
LandOfFree
Treatment of internal radiation damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of internal radiation damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of internal radiation damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-424563